AB SCIENCE SA (ABSCF:OTCMKTS)
$0 None (None%)
Analysed AB SCIENCE SA (ABSCF:OTCMKTS) News Sources
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
19-02-2026
yahoo.com
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
06-08-2026
yahoo.com
AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million
10-08-2026
yahoo.com
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
17-08-2026
yahoo.com
AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection
29-09-2026
yahoo.com
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities
09-10-2026
yahoo.com
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.
12-10-2026
yahoo.com
What is the current price of AB SCIENCE SA (ABSCF:OTCMKTS)?
The current price of AB SCIENCE SA (ABSCF:OTCMKTS) is $0.
AB SCIENCE SA (ABSCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is $None.
AB SCIENCE SA (ABSCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS) is 62 out of 100.
What is the most recent average sentiment for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent sentiment for AB SCIENCE SA (ABSCF:OTCMKTS) is .
SEC-8K** Filing Available For AB SCIENCE SA (ABSCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.